CorpDev.Org
Daily News for Dealmakers
Big Deal
Banco Santander to Acquire Webster Financial in $12.2 Billion Cash-and-Stock Deal
null Banco Santander announced February 3rd, 2026 it will acquire Webster Financial Corporation for $12.2 billion in a cash and stock transaction, creating a top-ten retail and commercial bank in the U.S. by assets. Under the agreement, Webster...
KKR and Singtel Strike S$6.6 Billion Data Centre Deal, Accelerating Asia-Pacific Infrastructure Push
Singapore Telecommunications (Singtel) has agreed to sell its data centre business to KKR for S$6.6 billion ($4.9 billion), marking one of Southeast Asia's largest infrastructure transactions as of early 2026. The deal, announced February 4,...
Musk Faces Renewed SEC Scrutiny Over Twitter Stock Purchases in Ongoing Insider Trading Suit
Elon Musk's 2022 acquisition of Twitter, now X Corp, continues to draw regulatory fire from the U.S. Securities and Exchange Commission. On January 28, 2026, a federal appeals court in the Ninth Circuit revived the SEC's civil lawsuit accusing Musk...
Henkel Acquires Specialty Coatings Firm Stahl for €2.1 Billion in Strategic Industrial Push
Henkel AG & Co. KGaA has agreed to purchase Stahl Holdings B.V., a Dutch specialty coatings provider, from private equity firm Wendel SE for €2.1 billion, marking a key expansion in **adhesives and coatings** for flexible substrates. Set and...
Texas Instruments to Acquire Silicon Labs in $7.5 Billion Cash Deal, Strengthening Embedded Wireless Leadership
Texas Instruments agreed to acquire Silicon Labs in an all-cash transaction valued at $7.5 billion, or $231 per share, representing a 69% premium to Silicon Labs' unaffected closing price. The deal, announced February 4, 2026, combines Texas...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Humana Nears $1 Billion Acquisition of MaxHealth, Targets Florida Primary Care Expansion
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores Humana's strategy to deepen vertical integration...
Eli Lilly Bets $2.4 Billion on Orna Therapeutics to Advance In Vivo Cell Therapies
Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion in cash, securing access to proprietary circular RNA technology for in vivo cell engineering in autoimmune diseases and oncology. Set and exceed synergy goals with benchmarks...
Novartis Doubles Down on Early-Stage M&A Strategy as Near-Launch Assets Become Scarce
null Novartis is reinforcing its commitment to acquiring early-stage pipeline assets and clinical-stage candidates, even as the pharmaceutical giant faces intensifying competition for late-stage drug programs approaching regulatory approval. The...
Mubadala Exits Arcadia Consumer Healthcare as Bansk Group Assumes Full Control in Continuation Vehicle
Mubadala Capital has sold its minority stake in Arcadia Consumer Healthcare to funds managed by Bansk Group, marking the end of a four-year partnership that tripled the platform's revenue and sharpened its profitability. The transaction, structured...
Revolution Medicines Stock Plunges 20% as Merck Ends $28-32 Billion Acquisition Talks Over Valuation Rift
Merck & Co. has terminated acquisition discussions with Revolution Medicines after failing to agree on price for a potential $28-32 billion deal, triggering a 20% drop in Revolution's shares and exposing tensions in **biotech M&A valuation** amid...
